YLR279W Antibody

What is YLR279W and why is it studied in yeast research?

YLR279W is a gene in Saccharomyces cerevisiae that encodes a specific protein (UniProt O13540). Studying this gene and its protein product helps researchers understand fundamental cellular processes in yeast, which often have conserved analogs in higher organisms. The antibody against this protein enables detection and quantification in various experimental contexts, providing insights into protein expression, localization, and function within yeast cells.

What are the primary applications for YLR279W Antibody?

YLR279W Antibody is primarily used in Western Blotting applications to detect endogenous levels of the target protein in yeast samples. Similar to other research antibodies, it may also be suitable for immunoprecipitation, immunohistochemistry, and immunofluorescence, though validation for these applications would be necessary. The antibody facilitates studies of protein expression patterns under different experimental conditions, protein-protein interactions, and subcellular localization .

What is the molecular weight of the protein detected by YLR279W Antibody?

While the specific molecular weight for YLR279W is not directly stated in the search results, similar yeast proteins typically appear between 25-150 kDa on Western blots. The exact molecular weight would depend on post-translational modifications and should be verified experimentally when using this antibody. Some antibodies, like IgM shown in the search results, detect proteins around 80 kDa .

How should YLR279W Antibody be stored to maintain optimal activity?

For optimal performance, store YLR279W Antibody according to manufacturer specifications, typically at -20°C for long-term storage. Similar to the IgM antibody mentioned in the search results, it's advisable not to aliquot the antibody unless specifically recommended by the manufacturer, as repeated freeze-thaw cycles can diminish activity. When in use, keep the antibody on ice and return to storage promptly after use .

What controls should be included when using YLR279W Antibody in Western blotting experiments?

When designing experiments with YLR279W Antibody, include the following controls:

• Positive control: Wild-type yeast strain expressing normal levels of the target protein

• Negative control: Yeast strain with YLR279W gene deletion if available

• Loading control: Antibody against a housekeeping protein (e.g., actin or GAPDH)

• Non-specific binding control: Secondary antibody alone without primary antibody

These controls help validate specificity and ensure reliable interpretation of experimental results, particularly when analyzing complex yeast extracts where cross-reactivity might occur.

What sample preparation methods are recommended for detection of YLR279W in yeast lysates?

For optimal detection of YLR279W protein:

• Harvest yeast cells during the appropriate growth phase

• Lyse cells using glass bead disruption or enzymatic methods with a buffer containing protease inhibitors

• Clear lysates by centrifugation (14,000 × g for 10 minutes at 4°C)

• Quantify protein concentration using Bradford or BCA assays

• Denature samples in SDS loading buffer at 95°C for 5 minutes

• Load 20-50 μg of total protein per lane for Western blotting

This approach preserves protein integrity while minimizing degradation that could affect antibody recognition and experimental outcomes.

How can YLR279W Antibody be used in combination with machine learning approaches for binding prediction?

Recent advances in antibody research incorporate machine learning models to predict antibody-antigen binding. For YLR279W Antibody, researchers could apply library-on-library approaches where the antibody is tested against multiple antigen variants to identify specific binding pairs. These experimental data can train machine learning models that analyze many-to-many relationships between antibodies and antigens, potentially predicting binding to novel variants of the target protein or even cross-reactivity with related proteins .

Active learning strategies, as described in recent research, can reduce experimental costs by starting with a small labeled subset of binding data and iteratively expanding the dataset based on model predictions. This approach has shown to reduce the required number of antigen variant tests by up to 35%, significantly accelerating the research process .

What strategies exist for improving YLR279W Antibody specificity for evolving yeast strains?

Drawing parallels from the GUIDE team's approach to antibody redesign for viral variants, researchers working with evolving yeast strains could employ computational methods to optimize YLR279W Antibody. This would involve:

• Structural modeling of the antibody-antigen interaction interface

• Identifying key binding residues using molecular dynamics simulations

• Designing targeted mutations to improve binding to variant protein forms

• Screening redesigned antibodies against a panel of yeast strain variants

The GUIDE platform combining AI and supercomputing demonstrates how antibodies can be redesigned to restore effectiveness against evolving targets. This approach could be adapted for yeast research to maintain antibody effectiveness across different strain backgrounds .

How can computational approaches optimize experimental design when using YLR279W Antibody?

Computational approaches can significantly enhance experimental efficiency when working with YLR279W Antibody:

• Structural bioinformatics tools can predict epitope accessibility in different experimental conditions

• Molecular simulations can identify optimal buffer compositions and incubation parameters

• Machine learning algorithms can analyze preliminary data to guide subsequent experimental iterations

As demonstrated in antibody research, these computational methods can reduce the theoretical design space from 10^17 possibilities to a manageable number of candidates for laboratory evaluation, substantially reducing time and resource requirements .

What are common causes of false positive/negative results when using YLR279W Antibody, and how can they be addressed?

This systematic approach to troubleshooting helps identify and resolve issues that may arise during experimental procedures with YLR279W Antibody.

How can signal-to-noise ratio be optimized when using YLR279W Antibody in Western blotting?

To optimize signal-to-noise ratio:

• Determine optimal primary antibody dilution through titration experiments (starting with 1:1000 as suggested for similar antibodies)

• Optimize blocking conditions (test different blocking agents: BSA, milk, commercial blockers)

• Adjust incubation times and temperatures (compare overnight at 4°C vs. 1-2 hours at room temperature)

• Increase wash stringency with higher salt concentrations or mild detergents

• Use enhanced chemiluminescence (ECL) substrates with sensitivity appropriate for your target abundance

• Consider using fluorescently-labeled secondary antibodies for more quantitative results

These optimization steps ensure maximum detection of the target protein while minimizing background interference.

How can epitope masking be addressed when YLR279W detection is inconsistent across sample preparations?

When epitope masking causes inconsistent detection:

• Test different lysis buffers with varying detergent compositions (RIPA, NP-40, Triton X-100)

• Compare different sample denaturation conditions (temperature, time, reducing agents)

• Try native vs. denaturing conditions if the epitope might be conformational

• Consider enzymatic or chemical treatments to expose hidden epitopes

• Test different membrane types (PVDF vs. nitrocellulose) for Western blotting

• Explore alternative fixation methods if using the antibody for microscopy

These approaches help overcome epitope accessibility issues that may arise from protein folding, protein-protein interactions, or post-translational modifications.

How does the performance of YLR279W Antibody compare across different experimental systems?

This comparative analysis helps researchers select appropriate conditions when adapting YLR279W Antibody across different experimental platforms.

How can YLR279W Antibody be integrated into multi-omics research approaches?

YLR279W Antibody can enhance multi-omics studies by providing protein-level validation of findings from other methodologies:

• Proteomics: Use the antibody to confirm mass spectrometry identification of YLR279W protein or post-translational modifications

• Transcriptomics: Correlate RNA-seq expression data with protein levels detected by Western blotting

• Genomics: Validate the effects of genetic variants on protein expression or localization

• Interactomics: Confirm protein-protein interactions identified in high-throughput screens

• Phenomics: Connect protein expression patterns with observable yeast phenotypes

This integration strengthens research findings by providing orthogonal validation across multiple data types.

What considerations are important when adapting protocols from similar yeast antibodies to YLR279W Antibody?

When adapting protocols developed for other yeast antibodies:

• Adjust antibody concentration based on the specific activity of YLR279W Antibody

• Consider the subcellular localization of the target protein, which may require specialized extraction methods

• Evaluate the abundance of the target protein, which affects detection methodology sensitivity requirements

• Assess potential cross-reactivity with homologous proteins in the experimental system

• Optimize incubation times based on the specific binding kinetics of YLR279W Antibody

• Validate all protocol modifications with appropriate controls before proceeding to full experiments

This careful adaptation process ensures successful application of YLR279W Antibody in established experimental workflows.